VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / Sun Peak Metals Corp. (TSXV:PEAK)(OTCQB:SUNPF) ("Sun Peak" or the "Company") is pleased to announce the successful completion of its previously an ...
Apollo Silver Corp. ("Apollo Silver" or the "Company") (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF) is pleased to announce that, ...
Central Chidlom has firmly established itself as a luxury flagship under the identity "The Store of Bangkok." It has become a ...
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced ...
Achieves another quarter of higher-than-expected revenue and profitability and hits the top-end of cash flow guidanceQNX division achieves highest revenue quarter everSecure Communications division be ...
MURFREESBORO, TN / ACCESS Newswire / December 18, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it has invested $89.2 million, including transaction costs, in four separate tr ...
SUNNYVALE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- eGain Corporation (NASDAQ: EGAN), the leading AI knowledge platform for customer experience, today announced that Achmea, one of Europe's largest c ...
Air Lease (NYSE: AL) announced today that its Class A common stockholders have voted to approve the previously announced definitive merger agreement, dated as of September 1, 2025, pursuant to which ...
MINNEAPOLIS, MN / ACCESS Newswire / December 18, 2025 / Air T, Inc. (NASDAQ:AIRT) is pleased to announce the successful closing of its acquisition of Regional Express Holdings Limited (Rex), Australia ...
WOBURN, MASSACHUSETTS / ACCESS Newswire / December 18, 2025 / Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered marketing technology, today announced financial results for its fiscal 2025 ...
6h
Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT in Brain Cancer
Phase 1 trial in aggressive brain cancer (Glioblastoma) is the first clinical trial of uTREAT belonging to Curasight's treatment platformNo patient safety issues were reported The dosing marks ...
Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea", or the "Company"), a clinical-stage biopharmaceutical company developing innovative treatments that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback